| Execution period | 15 years (with 3-year lock-in) |
|---|---|
| hospital beds | 50 beds |
NSE filing, NSE: ABH. Summary written from the filing by ALFA Finder's alert engine.
ABH Healthcare Ltd: key numbers
- Share price
- ₹40.75
- Market cap
- ₹46.58 Cr
- Revenue (annual)
- ₹52.51 Cr
- Net profit (annual)
- ₹5.65 Cr
- P/E (TTM)
- 8.2×Sector 34.1×
- Promoter holding
- 69.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ABH Healthcare Ltd
All →ABH Healthcare Business Update
ABH Healthcare Limited has deferred the execution of its lease-and-management agreement with Sri Kailash Multispeciality Hospital. Discussions regarding final terms and conditions remain ongoing between the parties.
ABH Healthcare Board Meeting Outcome
ABH Healthcare appointed a new Company Secretary and Compliance Officer, and a new Secretarial Auditor for FY 2026-27.
ABH Healthcare Management Change
ABH Healthcare announces resignation of Company Secretary & Compliance Officer Rahul Sharma effective October 7, 2026. A successor will be appointed and intimated separately.
ABH Healthcare Price Movement Clarification
ABH Healthcare responded to an NSE query regarding significant movement in its share price. The company confirmed the movement is market-driven and involves no undisclosed information.
ABH Healthcare Debt & Borrowing: ₹17 Cr
ABH Healthcare has repaid ₹17.00 Crore of outstanding borrowings using net proceeds from its IPO. This utilization aligns with the objects stated in the prospectus.
- Value
- ₹17.00 Cr
Other partnership announcements
All →Blue Cloud Softech Solutions Partnership
Blue Cloud Softech signed an MoU with Ghana-based Kasten Development to explore business development in Ghana and Africa. No monetary value was disclosed.
V2 Retail Partnership
V2 Retail signed a long-term exclusive partnership giving Cupid 400 sq ft across 425+ stores and future stores. Products are targeted network-wide by mid-December 2026.
- Execution
- Long-term, with supply targeted across the network by mid-December 2026
Ravindra Energy Partnership
Ravindra Energy's jointly controlled company EIM signed a strategic MoU with Sorigin Green Mobility. The MoU targets 500 electric heavy commercial vehicles over two years.
- Execution
- 2 years
- electric heavy commercial vehicles deployment
- 500.0 vehicles
Bacil Pharma Partnership
Bacil Pharma's wholly owned subsidiary signed an R&D agreement with Efdee Pharma for pharmaceutical products. The estimated project cost is Rs. 35 Crore.
- Value
- ₹35.00 Cr
Alembic Pharmaceuticals Partnership
Alembic Pharmaceuticals expanded its strategic collaboration with DifGen Pharmaceuticals to commercialize over 20 complex generic products in the US. The portfolio targets a US$5 billion market.
- From
- DifGen Pharmaceuticals
- Execution
- Initial launches from FY28
Grasim Industries Partnership
Grasim Industries, Aditya Birla Renewables, and Suzlon Energy signed a Memorandum of Understanding to develop India's first recyclable wind turbine blades. The partnership utilizes Grasim's Recyclamine technology.